返回 Agenda
Session 1: Innovation and New Technologies – Challenges and Opportunities
Session Chair(s)
Peter Richardson, PhD
Head of Quality, Specialised Scientific Disciplines Department
European Medicines Agency, Netherlands
The session will review digitalisation (Pharma 4.0), from development and manufacture to patient use. Enablers and controls needed to define and implement a Holistic Control Strategy, delivery systems and engagement with regulatory authorities on innovation will be presented.
Speaker(s)
Bridging Industry 4.0 and Pharma 4.0 – the Holistic Control Strategy
Christian Woelbeling, MSc
Werum IT Solutions GmbH, Germany
Senior Director, Global Accounts
Digitalisation of Biotech Processes
Patrick Sagmeister, PhD
Exputec GmbH, Austria
Chief Technology Officer
Perspectives of Digitalisation: Continuous Manufacturing to Patient Interface
Gordon Muirhead, PhD
Leicester School of Pharmacy at De Montfort University, United Kingdom
Visiting Professor of Pharmaceutics